Healthcare-associated infections (HCAIs) are a major source of morbidity and mortality and
are the second most prevalent cause of death. Furthermore, it has been reported that for …

Background Clostridioides difficile is a Gram-positive anaerobic bacterium, which causes
Clostridioides difficile infection (CDI). It has been recognised as a leading cause of …

In the last three decades, Clostridium difficile infection (CDI) has increased in incidence and
severity in many countries worldwide. The increase in CDI incidence has been particularly …

Clostridium difficile infections are the leading cause of health care–associated infectious
diarrhea, posing a significant risk for both medical and surgical patients. Because of the …

Intra-abdominal infections (IAI) are an important cause of morbidity and are frequently
associated with poor prognosis, particularly in high-risk patients. The cornerstones in the …

Clostridium difficile (C. difficile) infection (CDI) is the most common cause of healthcare-
associated infections in US hospitals. The epidemic strain NAP1/BI/ribotype 027 accounts …

Toxigenic culture and cytotoxicity assays are standard tests for detecting C. difficile infection
(CDI). Others include immunochromatographic strips, a rapid diagnostic test that detects …

Clostridioides difficile infection (CDI) is the leading cause of health care–associated
infections in the United States. The increasing incidence and recurrence rates of CDI …

Background: Procalcitonin (PCT) is a serum biomarker currently suggested by the Surviving
Sepsis Campaign to aid in determination of the appropriate duration of therapy in sepsis …

These updated guidelines from the American Society of Transplantation Infectious Diseases
Community of Practice address the prevention and management of Clostridium difficile …